SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610717-24-000341
Filing Date
2024-06-17
Accepted
2024-06-17 16:43:24
Documents
1
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 7226
  Complete submission text file 0001610717-24-000341.txt   8678
Mailing Address C/O ONCOMED PHARMACEUTICALS, INC. 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address
Gould Terry P (Reporting) CIK: 0001553470 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37719 | Film No.: 241048893

Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Issuer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)